Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2022 | 4 |
2023 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Durability of Immune Response to ChAdOx1-nCoV-19 Vaccine in Solid Cancer Patients Undergoing Anticancer Treatment.
Vaccines (Basel). 2022 Oct 5;10(10):1662. doi: 10.3390/vaccines10101662.
Vaccines (Basel). 2022.
PMID: 36298528
Free PMC article.
Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignancy patients by treatment regimen versus healthy controls: A prospective, multicenter observational study.
Teeyapun N, Luangdilok S, Pakvisal N, Sainamthip P, Mingmalairak S, Poovorawan N, Sitthideatphaiboon P, Parinyanitikul N, Sriuranpong V, Namkanisorn T, Inthasuwan P, Angspatt P, Wongchanapat P, Bamrungnam A, Leeleakpai N, Uttha S, Jaichum S, Kongkaew P, Suksanong C, Veranitinun R, Prasomphol A, Sartsuk C, Patcharajutanon C, Preaprang S, Choengsamor H, Phongwan R, Preeyasaksa C, Phaibulvatanapong E, Suntronwong N, Yorsaeng R, Vichaiwattana P, Wanlapakorn N, Kerr SJ, Poovorawan Y, Wanchaijiraboon P, Tanasanvimon S.
Teeyapun N, et al. Among authors: wanchaijiraboon p.
EClinicalMedicine. 2022 Oct;52:101608. doi: 10.1016/j.eclinm.2022.101608. Epub 2022 Aug 11.
EClinicalMedicine. 2022.
PMID: 35971500
Free PMC article.
Item in Clipboard
Immunogenicity after a Third COVID-19 mRNA Booster in Solid Cancer Patients Who Previously Received the Primary Heterologous CoronaVac/ChAdOx1 Vaccine.
Luangdilok S, Wanchaijiraboon P, Pakvisal N, Susiriwatananont T, Zungsontiporn N, Sriuranpong V, Sainamthip P, Suntronwong N, Vichaiwattana P, Wanlapakorn N, Poovorawan Y, Teeyapun N, Tanasanvimon S.
Luangdilok S, et al. Among authors: wanchaijiraboon p.
Vaccines (Basel). 2022 Sep 26;10(10):1613. doi: 10.3390/vaccines10101613.
Vaccines (Basel). 2022.
PMID: 36298478
Free PMC article.
Item in Clipboard
Vaccine-Related adverse events following AZD1222 (ChAdOx1-nCoV-19) Covid-19 vaccine in solid malignancy patients receiving cancer treatment, as compared to age-matched healthy controls.
Pakvisal N, Sainamthip P, Teeyapun N, Luangdilok S, Wanlapakorn N, Yorsaeng R, Poovorawan Y, Pakvisal P, Susiriwatananont T, Zungsontiporn N, Sriuranpong V, Tanasanvimon S, Wanchaijiraboon P.
Pakvisal N, et al. Among authors: wanchaijiraboon p.
Hum Vaccin Immunother. 2022 Nov 30;18(6):2094149. doi: 10.1080/21645515.2022.2094149. Epub 2022 Jul 1.
Hum Vaccin Immunother. 2022.
PMID: 35776836
Free PMC article.
Item in Clipboard
Safety Following COVID-19 Booster Vaccine with BNT162b2 Compared to mRNA-1273 in Solid Cancer Patients Previously Vaccinated with ChAdOx1 or CoronaVac.
Wanchaijiraboon P, Sainamthip P, Teeyapun N, Luangdilok S, Poovorawan Y, Wanlapakorn N, Tanasanvimon S, Sriuranpong V, Susiriwatananont T, Zungsontiporn N, Pakvisal N.
Wanchaijiraboon P, et al.
Vaccines (Basel). 2023 Feb 3;11(2):356. doi: 10.3390/vaccines11020356.
Vaccines (Basel). 2023.
PMID: 36851234
Free PMC article.
Item in Clipboard
Cyclin D1 expression as a potential prognostic factor in advanced KRAS-mutant non-small cell lung cancer.
Luangdilok S, Wanchaijiraboon P, Chantranuwatana P, Teerapakpinyo C, Shuangshoti S, Sriuranpong V.
Luangdilok S, et al. Among authors: wanchaijiraboon p.
Transl Lung Cancer Res. 2019 Dec;8(6):959-966. doi: 10.21037/tlcr.2019.12.01.
Transl Lung Cancer Res. 2019.
PMID: 32010574
Free PMC article.
Item in Clipboard
Cite
Cite